
Guillermo de Velasco, MD, PhD
Advertisement
Articles by Guillermo de Velasco, MD, PhD

Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves RP1/Nivolumab for Progression on Anti–PD-1 Therapy in Melanoma
2
The Lowest-Ever Hazard Ratio in Multiple Myeloma Bispecific Trials?
3
Why Earlier CAR T-Cell Therapy May Benefit Patients With Multiple Myeloma
4
GLP-1 Receptor Agonists and Cancer: Renewed Momentum for Metabo-Oncology
5

